Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 May 2007, Vol. 109, No. 10, pp. 4590.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Powers, A.
Right arrow Articles by Haspel, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Powers, A.
Right arrow Articles by Haspel, R. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents

CORRESPONDENCE

Apparent nonhemolytic alloantibody-induced red-cell antigen loss from transfused erythrocytes

To the editor:

Zimring et al1 demonstrated alloantibody-induced nonhemolytic antigen loss following red blood cell (RBC) transfusion in a murine model. Human RBC antigen suppression has been primarily described in the setting of autoimmune hemolytic anemia. It is most frequently associated with the Kell blood group antigens, but has been reported in others, including the Rh, Kidd, Duffy, and Lutheran blood groups.1 The frequency of alloantibody-induced antigen loss following the transfusion of incompatible blood in humans is unknown. We observed alloantibody-induced surface antigen loss in a patient following RBC transfusion.

An 86-year-old group AB Rh-(D) negative male with a history of chronic lymphocytic leukemia (CLL) received 2 units of group A Rh-(D) negative RBCs for symptomatic anemia. An antibody screen (ImmucorGamma, Norcross, GA) performed prior to transfusion demonstrated no alloantibodies. A follow-up antibody screen performed 14 days later demonstrated a new anti-Jkb alloantibody. Forward typing showed mixed-field agglutination with the anti-B reagent, confirming the persistence of transfused group A donor RBCs (Table 1). The direct antiglobulin test (DAT) was negative using both monospecific anti-IgG and anti-C3b reagents, and an eluate was prepared (Gamma Elu-Kit, Norcross, GA) and showed no reactivity when tested against a panel of screening cells using polyethylene glycol enhancement (ImmucorGamma). No abnormalities in the patient's lactose dehydrogenase (LDH) or total bilirubin were noted, and haptoglobin was not decreased. Segments from the transfused RBC components were subsequently antigen typed (Gamma Biologicals Inc, Houston, TX; ImmucorGamma). Both donor red cell units were positive for the Jkb antigen. A pretransfusion patient sample was antigen typed and found to be negative for the Jkb antigen. Antigen typing of the patient's posttransfusion sample, however, showed no evidence of Jkb-positive red cells.


View this table:
[in this window]
[in a new window]

 
Table 1. Antigen typing of patient pre- and posttransfusion samples and transfused RBC components

 
The lack of Jkb antigen positivity in the patient's posttransfusion sample was puzzling, since both transfused components were Jkb positive, and transfused RBCs clearly remained in circulation. Interference with Jkb antigen typing due to bound anti-Jkb antibody was unlikely, since the posttransfusion DAT and eluate were negative. Phenotypes obtained from the transfused components and the patient's pre- and posttransfusion samples were directly compared (Table 1). Based on the observed antigen typings of the donor red-cell units and evidence for mixed-field agglutination in the patient's posttransfusion specimen for C, K, Fya, Fyb, N, and S antigens, there was clear evidence for persistence of donor cells from both transfused units (Table 1). C-antigen mixed-field agglutination in the posttransfusion sample demonstrated survival of RBCs from component 1, while Kell mixed-field antigen agglutination in the posttransfusion sample demonstrated survival of RBCs from component 2.

The failure to detect Jkb antigen on circulating red cells in this patient's posttransfusion specimen supports the findings by Zimring et al, and suggests that in human subjects, alloantibodies may specifically remove their target antigen from donor RBCs without further compromising survival of these cells. While autoantibody-mediated transient loss of RBC antigen expression on transfused RBCs has been previously reported, this patient represents the first example of antigen suppression following transfusion in a patient without evidence of autoimmune hemolytic anemia.24

Authorship

Correspondence: Amy Powers, Department of Pathology, Beth Israel Deaconess Medical Center, Yamins 309, 330 Brookline Ave, Boston, MA 02215; e-mail: apowers1{at}bidmc.harvard.edu.

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Amy Powers, Monique Mohammed, Lynne Uhl, and Richard L. Haspel

References

  1. Zimring JC, Hair GA, Chadwick TE, et al. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005; 106:1105–1112.[Abstract/Free Full Text]

  2. Vengelen-Tyler V, Gonzalez B, Garratty G, et al. Acquired loss of red cell Kell antigens. Br J Haematol 1987; 65:231–234.[Medline] [Order article via Infotrieve]

  3. Brendel WL, Issitt PD, Moore RE, et al. Temporary reduction of red cell Kell system antigen expression and transient production of anti-Kpb in a surgical patient. Biotest Bull 1985; 2:201–206.

  4. Williamson LM, Poole J, Redman C, et al. Transient loss of proteins carrying Kell and Lutheran red cell antigens during consecutive relapses of autoimmune thrombocytopenia. Br J Haematol 1994; 87:805–812.[Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
J. C. Zimring, C. M. Cadwell, T. E. Chadwick, S. L. Spitalnik, D. A. Schirmer, T. Wu, C. A. Parkos, and C. D. Hillyer
Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes
Blood, September 15, 2007; 110(6): 2201 - 2208.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Powers, A.
Right arrow Articles by Haspel, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Powers, A.
Right arrow Articles by Haspel, R. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020